Literature DB >> 9575823

Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus.

D S Ludwig1, K G Mountjoy, J B Tatro, J A Gillette, R C Frederich, J S Flier, E Maratos-Flier.   

Abstract

Melanin-concentrating hormone (MCH) and alpha-melanocyte-stimulating hormone (alpha-MSH) demonstrate opposite actions on skin coloration in teleost fish. Both peptides are present in the mammalian brain, although their specific physiological roles remain largely unknown. In this study, we examined the interactions between MCH and alpha-MSH after intracerebroventricular administration in rats. MCH increased food intake in a dose-dependent manner and lowered plasma glucocorticoid levels through a mechanism involving ACTH. In contrast, alpha-MSH decreased food intake and increased glucocorticoid levels. MCH, at a twofold molar excess, antagonized both actions of alpha-MSH. alpha-MSH, at a threefold molar excess, blocked the orexigenic properties of MCH. MCH did not block alpha-MSH binding or the ability of alpha-MSH to induce cAMP in cells expressing either the MC3 or MC4 receptor, the principal brain alpha-MSH receptor subtypes. These data suggest that MCH and alpha-MSH exert opposing and antagonistic influences on feeding behavior and the stress response and may function in a coordinate manner to regulate metabolism through a novel mechanism mediated in part by an MCH receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575823     DOI: 10.1152/ajpendo.1998.274.4.E627

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  37 in total

1.  Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.

Authors:  Dan Georgescu; Venetia Zachariou; Michel Barrot; Michihiro Mieda; Jon T Willie; Amelia J Eisch; Masashi Yanagisawa; Eric J Nestler; Ralph J DiLeone
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

2.  Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons.

Authors:  Yang Yao; Li-Ying Fu; Xiaobing Zhang; Anthony N van den Pol
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-01-18       Impact factor: 3.619

Review 3.  Neuronal control of energy homeostasis.

Authors:  Qian Gao; Tamas L Horvath
Journal:  FEBS Lett       Date:  2007-12-03       Impact factor: 4.124

Review 4.  Behavioral controls of food intake.

Authors:  Stephen C Benoit; Andrea L Tracy
Journal:  Peptides       Date:  2008-01       Impact factor: 3.750

Review 5.  Brain circuits regulating energy homeostasis.

Authors:  Alfonso Abizaid; Tamas L Horvath
Journal:  Regul Pept       Date:  2008-03-25

Review 6.  Counterregulation of insulin by leptin as key component of autonomic regulation of body weight.

Authors:  Katarina T Borer
Journal:  World J Diabetes       Date:  2014-10-15

7.  MCH Regulates SIRT1/FoxO1 and Reduces POMC Neuronal Activity to Induce Hyperphagia, Adiposity, and Glucose Intolerance.

Authors:  Omar Al-Massadi; Mar Quiñones; Jerome Clasadonte; René Hernandez-Bautista; Amparo Romero-Picó; Cintia Folgueira; Donald A Morgan; Imre Kalló; Violeta Heras; Ana Senra; Samuel C Funderburk; Michael J Krashes; Yara Souto; Miguel Fidalgo; Serge Luquet; Melissa J Chee; Monica Imbernon; Daniel Beiroa; Lucía García-Caballero; Rosalia Gallego; Brian Y H Lam; Giles Yeo; Miguel Lopez; Zsolt Liposits; Kamal Rahmouni; Vincent Prevot; Carlos Dieguez; Ruben Nogueiras
Journal:  Diabetes       Date:  2019-09-16       Impact factor: 9.461

8.  Microinjections of melanin concentrating hormone into the nucleus tractus solitarius of the rat elicit depressor and bradycardic responses.

Authors:  S N Brown; V C Chitravanshi; K Kawabe; H N Sapru
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

9.  Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice.

Authors:  E Kokkotou; D O Espinoza; D Torres; I Karagiannides; S Kosteletos; T Savidge; M O'Brien; C Pothoulakis
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

10.  Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

Authors:  Nima Davoodi; Mikhail Kalinichev; Sergei A Korneev; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.